1. Home
  2. HUMA vs AMTX Comparison

HUMA vs AMTX Comparison

Compare HUMA & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.58

Market Cap

165.7M

Sector

Health Care

ML Signal

HOLD

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$2.15

Market Cap

134.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUMA
AMTX
Founded
2004
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
165.7M
134.2M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
HUMA
AMTX
Price
$0.58
$2.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
2
Target Price
$6.19
$12.00
AVG Volume (30 Days)
5.0M
680.6K
Earning Date
05-15-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
79.37
32.98
EPS
N/A
N/A
Revenue
$2,038,000.00
$77,194,000.00
Revenue This Year
$444.16
$49.77
Revenue Next Year
$248.39
$57.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
174.60
52 Week Low
$0.53
$1.30
52 Week High
$2.55
$3.80

Technical Indicators

Market Signals
Indicator
HUMA
AMTX
Relative Strength Index (RSI) 44.13 65.29
Support Level $0.54 $2.07
Resistance Level $0.75 $2.77
Average True Range (ATR) 0.03 0.12
MACD 0.00 0.01
Stochastic Oscillator 37.55 100.00

Price Performance

Historical Comparison
HUMA
AMTX

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: